Free Trial

Krystal Biotech (KRYS) Earnings Date, Estimates & Call Transcripts

Krystal Biotech logo
$150.76 +3.12 (+2.11%)
Closing price 04:00 PM Eastern
Extended Trading
$150.85 +0.09 (+0.06%)
As of 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Krystal Biotech Earnings Summary

Krystal Biotech announced Q2 2025 earnings on August 4, 2025, reporting an EPS of $1.29, which beat the consensus estimate of $1.08 by $0.21. Quarterly revenue was reported to be $96.04 million, above analyst estimates of $95.42 million. With a trailing EPS of $4.92 and a P/E Ratio of 30.64, Krystal Biotech's earnings are expected to grow 64.17% next year, from $6.14 to $10.08 per share.

Upcoming Q3
Earnings Date
Nov. 3Before Market OpensEstimated
Consensus EPS
(Aug. 4)
$1.08
Actual EPS
(Aug. 4)
$1.29 Beat By $0.21
Actual Revenue
(Aug. 4)
$96.04M

Q2 2025 Earnings Resources

KRYS Upcoming Earnings

Krystal Biotech's next earnings date is estimated for Monday, November 3, 2025, based on past reporting schedules.

Get Krystal Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Krystal Biotech and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

KRYS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KRYS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Krystal Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252$1.31$1.56$1.44
Q2 20252$1.12$1.26$1.19
Q3 20252$1.06$1.14$1.10
Q4 20252$1.09$1.61$1.35
FY 2025 8 $4.58 $5.57 $5.08
Q1 20261$1.40$1.40$1.40
Q2 20261$1.88$1.88$1.88
Q3 20261$2.16$2.16$2.16
Q4 20261$2.93$2.93$2.93

Krystal Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/3/2025
(Estimated)
--------
8/4/2025Q2 2025$1.08$1.29+$0.21$1.29$95.42M$96.04M
5/6/2025Q1 2025$1.38$1.20 -$0.18$1.20$98.66M$88.18M
2/24/2025Q4 2024$1.29$1.52+$0.23$1.52$91.35M$91.10M
11/4/2024Q3 2024$0.84$0.91+$0.07$0.91$82.94M$83.84M
8/5/2024Q2 2024$0.50$0.53+$0.03$1.19$65.27M$70.28M
5/6/2024Q1 2024$0.20$0.03 -$0.17$0.03$47.37M$45.25M
2/26/2024Q4 2023-$0.52$0.30+$0.82$0.30$27.43M$42.14M
11/6/2023Q3 2023-$1.10$2.79+$3.89-$4.13$6.29M$8.60M

Krystal Biotech Earnings - Frequently Asked Questions

Krystal Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based off last year's report dates. Learn more on KRYS's earnings history.

In the previous quarter, Krystal Biotech (NASDAQ:KRYS) reported $1.29 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.21. Learn more on analysts' earnings estimate vs. KRYS's actual earnings.

The conference call for Krystal Biotech's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Krystal Biotech's latest earnings report can be read online.
Read Transcript

Krystal Biotech's earnings report can be found in their filing with the SEC.
View SEC filing

Krystal Biotech (NASDAQ:KRYS) has a recorded annual revenue of $290.52 million.

Krystal Biotech (NASDAQ:KRYS) has a recorded net income of $89.16 million. KRYS has generated $4.92 earnings per share over the last four quarters.

Krystal Biotech (NASDAQ:KRYS) has a trailing price-to-earnings ratio of 30.64 and a forward price-to-earnings ratio of 24.55.

Krystal Biotech's earnings are expected to grow from $6.14 per share to $10.08 per share in the next year, which is a 64.17% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:KRYS) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners